CHRISTOPHER GREEN: Open Payments
NPI 1902284342 · LEBANON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,492 in 139 payments from 28 companies in 2025. Trend: 2023 $2,252 · 2024 $2,536 · 2025 $2,492
Food & beverage: $2,492
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $575 |
| AstraZeneca Pharmaceuticals LP | 12 | $280 |
| Amgen Inc. | 14 | $187 |
| Lilly USA, LLC | 10 | $176 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $148 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $146 |
| Exact Sciences Corporation | 6 | $118 |
| Novo Nordisk Inc | 6 | $111 |
| GlaxoSmithKline, LLC. | 5 | $103 |
| Medtronic, Inc. | 4 | $69 |
Products named: UBRELVY, VRAYLAR, Kerendia, CAPLYTA, MOUNJARO, QULIPTA, Cologuard Collection Kit, BREZTRI.
Industry payments across IN — which companies pay providers there.
